NR5A2/HSD3B1 pathway promotes cellular resistance to second-generation antiandrogen darolutamide. 査読 国際誌

@Shiota M, @Ushijima M, @Tsukahara S, @Nagakawa S, #Blas L, @Takamatsu D, @Kobayashi S, @Matsumoto T, @Inokuchi J, @Eto M:

Drug Resist Updat   2023年9月

Fusion-targeted biopsy significantly improves prostate cancer detection in biopsy-naïve men. 査読 国際誌

2023年7月

Adverse Events of Abiraterone Acetate vs Enzalutamide. 査読 国際誌

#Blas L, @Shiota M, @Tsukahara S, @Nagakawa S, @Matsumoto T, @Eto M:

Urol Pract   2023年7月

Correlation between extended pelvic lymph node dissection and urinary incontinence at early phase after robot-assisted radical prostatectomy 招待 査読 国際誌

@Ken Lee, @Masaki Shiota, @Dai Takamatsu, @Miho Ushijima, @Leandro Blas, @Ayami Okabe, @Shunichi Kajioka, @Shunsuke Goto, @Fumio Kinoshita, @Takashi Matsumoto, @Keisuke Monji, @Eiji Kashiwagi, @Junichi Inokuchi, @Yoshinao Oda, @Masatoshi Eto

Int J Urol   2023年4月

Correlation between extended pelvic lymph node dissection and urinary incontinence at early phase after robot-assisted radical prostatectomy. 査読 国際誌

Int J Urol   2023年4月

Effectiveness and safety of radium-223 dichloride in patients with castration-resistant prostate cancer and bone metastases in real-world practice: A multi-institutional study. 査読 国際誌

@Matsumoto T, @Hori Y, @Shiota M, @Blas L, @Nakamura M, @Seki N, @Kuroiwa K, @Yokomizo A, @Morokuma F, @Kiyoshima K, @Eto M:

Int J Urol   2023年2月

Validation of user-friendly models predicting extracapsular extension in prostate cancer patients 査読 国際誌

@Leandro Blas, @Masaki Shiota, @Shohei Nagakawa, @Shigehiro Tsukahara, @Takashi Matsumoto, @Ken Lee, @Keisuke Monji, @Eiji Kashiwagi, @Junichi Inokuchi, @Masatoshi Eto

Asian J Urol   2023年1月

Novel nomogram to predict biochemical recurrence-free survival after radical prostatectomy 査読 国際誌

@Leandro Blas, @Masaki Shiota, @Dai Takamatsu, @Fumio Kinoshita, @Takashi Matsumoto, @Ken Lee, @Keisuke Monji, @Eiji Kashiwagi, @Junichi Inokuchi, @Masatoshi Eto

World J Urol   2023年1月

Psoas Muscle Volume Is a Predictive Marker of Fatigue and Anorexia in Prostate Cancer Patients Treated with Enzalutamide 招待 査読 国際誌

@Eiji Kashiwagi, @Masaki Shiota, @Ken Lee, @Keisuke Monji, @Hidekazu Naganuma, @Takashi Matsumoto, @Ario Takeuchi, @Junichi Inokuchi, @Masatoshi Eto

JMA J   2022年10月

Testosterone level in seminal vesicle fluid is a better indicator of erectile function than serum testosterone in patients with prostate cancer 査読 国際誌

@Eiji Kashiwagi, @Masaki Shiota, @Hidekazu Naganuma, @Keisuke Monji, @Kenjiro Imada, @Ken Lee, @Takashi Matsumoto, @Ario Takeuchi, @Junichi Inokuchi, @Masatoshi Eto

Int J Urol   2022年10月

Cancer genomic profiling identified dihydropyrimidine dehydrogenase deficiency in bladder cancer promotes sensitivity to gemcitabine 査読 国際誌

@Shigehiro Tsukahara, @Masaki Shiota, @Dai Takamatsu\, @Shohei Nagakawa, @Takashi Matsumoto, @Ryo Kiyokoba, @Mikako Yagi, @Daiki Setoyama, @Nozomi Noda, @Shinya Matsumoto, @Tetsutaro Hayashi, @Alberto Contreras-Sanz, @Peter C Black, @Junichi Inokuchi, @Kenichi Kohashi, @Yoshinao Oda, @Takeshi Uchiumi, @Masatoshi Eto, @Dongchon Kang

Sci Rep   2022年5月

An oral first-in-class small molecule RSK inhibitor suppresses AR variants and tumor growth in prostate cancer 査読 国際誌

@Miho Ushijima, @Masaki Shiota, @Takashi Matsumoto, @Eiji Kashiwagi, @Junichi Inokuchi, @Masatoshi Eto

Cancer Sci   2022年5月

Validation of models predicting lymph node involvement probability in patients with prostate cancer 査読 国際誌

@Leandro Blas, @Masaki Shiota, @Shohei Nagakawa, @Shigehiro Tsukahara, @Takashi Matsumoto, @Keisuke Monji, @Eiji Kashiwagi, @Ario Takeuchi, @Junichi Inokuchi, @Masatoshi Eto

Int J Urol   2022年5月

Prognostic impact of dose reduction in androgen receptor pathway inhibitors for castration-resistant prostate cancer 査読 国際誌

@Shigetomo Yamada, @Masaki Shiota, @Leandro Blas, @Takashi Matsumoto, @Eiji Kashiwagi, @Ario Takeuchi, @Junichi Inokuchi, @Ken-Ichiro Shiga, @Akira Yokomizo, @Masatoshi Eto

Prostate Int   2022年5月

Prognostic significance of risk stratification in CHAARTED and LATITUDE studies among Japanese men with castration-resistant prostate cancer 招待 査読 国際誌

@Sotaro Chikamatsu, @Masaki Shiota, @Shigetomo Yamada, @Leandro Blas, @Takashi Matsumoto, @Eiji Kashiwagi, @Junichi Inokuchi, @Ken-Ichiro Shiga, @Akira Yokomizo, @Masatoshi Eto

Prostate Int   2022年3月

Clinical impact of HSD3B1 polymorphism by metastatic volume and somatic HSD3B1 alterations in advanced prostate cancer 査読 国際誌

@Masaki Shiota, @Naohiro Fujimoto, @Yohei Sekino, @Shigehiro Tsukahara, @Shohei Nagakawa, @Dai Takamatsu, @Tatsuro Abe, @Fumio Kinoshita, @Shohei Ueda, @Miho Ushijima, @Takashi Matsumoto, @Eiji Kashiwagi, @Junichi Inokuchi, @Takeshi Uchiumi, @Yoshinao Oda, @Masatoshi Eto

Andrologia   2022年2月

Differential prognostic impact of complete blood count-related parameters by prior use of novel androgen receptor pathway inhibitors in docetaxel-treated castration-resistant prostate cancer patients 査読 国際誌

@Hiroki Kobayashi, @Masaki Shiota, @Nobuaki Sato, @Satoshi Kobayashi, @Takashi Matsumoto, @Keisuke Monji, @Eiji Kashiwagi, @Ario Takeuchi, @Junichi Inokuchi, @Ken-Ichiro Shiga, @Akira Yokomizo, @Masatoshi Eto

Anticancer Drugs   2022年1月

Anticancer Effect of Second-line Treatment for Castration-Resistant Prostate Cancer Following First-line Treatment with Androgen Receptor Pathway Inhibitors 査読 国際誌

@Takashi Matsumoto, @Masaki Shiota, @Shigetomo Yamada, @Leandro Blas, @Hidekazu Naganuma, @Ken Lee, @Keisuke Monji, @Eiji Kashiwagi, @Ario Takeuchi, @Junichi Inokuchi, @Ken-Ichiro Shiga, @Akira Yokomizo, @Masatoshi Eto

MA J   2022年1月

Predictive factors of survival outcomes in first-line therapy for metastatic castration-resistant prostate cancer 査読 国際誌

@Masaki Shiota, @Leandro Blas, @Satoshi Kobayashi, @Takashi Matsumoto, @Eiji Kashiwagi, @Ario Takeuchi, @Junichi Inokuchi, @Ken-Ichiro Shiga, @Akira Yokomizo, @Masatoshi Eto

Int J Urol   2022年1月

Prognostic Value of Lower Tract Urinary Symptoms in Clinically Regional Lymph Node-positive Prostate Cancer 査読 国際誌

@Leandro Blas, @Kosuke Ieiri, @Masaki Shiota, @Shohei Nagakawa, @Shigehiro Tsukahara, @Takashi Matsumoto, @Eiji Kashiwagi, @Ario Takeuchi, @Junichi Inokuchi, @Ken-Ichiro Shiga, @Akira Yokomizo, @Masatoshi Eto

Anticancer Res   2021年11月

The impact of single-nucleotide polymorphisms on intravesical recurrence after bacillus Calmette-Guérin therapy for non-muscle invasive bladder cancer in a genome-wide association study 査読 国際誌

2021年10月

Lactate Dehydrogenase Is a Serum Prognostic Factor in Clinically Regional Lymph Node-positive Prostate Cancer 査読 国際誌

@Leandro Blas, @Masaki Shiota, @Shigetomo Yamada, @Kosuke Ieiri, @Shohei Nagakawa, @Shigehiro Tsukahara, @Takashi Matsumoto, @Eiji Kashiwagi, @Ario Takeuchi, @Junichi Inokuchi, @Ken-Ichiro Shiga, @Akira Yokomizo, @Masatoshi Eto

Anticancer Res   2021年8月

Prognostic impact of prior local therapy in castration-resistant prostate cancer 査読 国際誌

@Mikifumi Koura, @Masaki Shiota, @Shohei Ueda, @Takashi Matsumoto, @Satoshi Kobayashi, @Keisuke Monji, @Eiji Kashiwagi, @Ario Takeuchi, @Junichi Inokuchi, @Ken-Ichiro Shiga, @Akira Yokomizo, @Masatoshi Eto

Jpn J Clin Oncol   2021年7月

Efficacy and safety of cabazitaxel therapy in elderly (≥75 years) patients with castration-resistant prostate cancer: A multiinstitutional study 査読 国際誌

2021年6月

Prognostic significance of complete blood count parameters in castration-resistant prostate cancer patients treated with androgen receptor pathway inhibitors 査読 国際誌

@Asako Machidori, @Masaki Shiota, @Satoshi Kobayashi, @Takashi Matsumoto, @Keisuke Monji, @Eiji Kashiwagi, @Ario Takeuchi, @Ryosuke Takahashi, @Junichi Inokuchi, @Masatoshi Eto

Urol Oncol   2021年6月

Differential Impact of TGFB1 Variation by Metastatic Status in Androgen-Deprivation Therapy for Prostate Cancer 査読 国際誌

@Masaki Shiota, @Naohiro Fujimoto, @Takashi Matsumoto, @Shigehiro Tsukahara, @Shohei Nagakawa, @Shohei Ueda, @Miho Ushijima, @Eiji Kashiwagi, @Ario Takeuchi, @Junichi Inokuchi, @Takeshi Uchiumi, @Masatoshi Eto

Front Oncol   2021年5月

Gene amplification of YB-1 in castration-resistant prostate cancer in association with aberrant androgen receptor expression 査読 国際誌

@Masaki Shiota, @Yohei Sekino, @Shigehiro Tsukahara, @Tatsuro Abe, @Fumio Kinoshita, @Kenjiro Imada, @Shohei Ueda, @Miho Ushijima, @Shohei Nagakawa, @Takashi Matsumoto, @Eiji Kashiwagi, @Ario Takeuchi, @Junichi Inokuchi, @Takeshi Uchiumi, @Yoshinao Oda, @Masatoshi Eto

Cancer Sci   2021年1月

Genomic characteristics revealed by targeted exon sequencing of testicular germ cell tumors in Japanese men 査読 国際誌

@Takashi Matsumoto, @Masaki Shiota, @Takeshi Uchiumi, @Shohei Ueda, @Shigehiro Tsukahara, @Takahiro Toshima. @Shinya Matsumoto, @Nozomi Noda, @Masatoshi Eto, @Dongchon Kang

international journal of urology   2020年10月

Doxycycline induces apoptosis via ER stress selectively to cells with a cancer stem cell-like properties: importance of stem cell plasticity 招待 査読 国際誌

@Takashi Matsumoto, @Takeshi Uchiumi, @Keisuke Monji, Mikako Yagi, @Daiki Setoyama, @Rie Amamoto, @Yuichi Matsushima, @Masaki Shiota, @Masatoshi Eto, @Dongchon Kang

ONCOGENESIS   6   2017年11月

Serum depletion induced cancer stem cell-like phenotype due to nitric oxide synthesis in oncogenic HRas transformed cells 招待 査読 国際誌

@Keisuke Monji, @Takeshi Uchiumi, @Saki Hoshizawa, @Mikako Yagi, @Takashi Matsumoto, @Daiki Setoyama, @Yuichi Matsushima, @Kazuhito Gotoh, @Rie Amamoto, @Donchon Kang

ONCOTARGET   7 ( 46 )   75221 - 75234   2016年11月

尿/血液循環腫瘍DNAを用いた泌尿器癌のモニタリング法の開発

2023年

橋渡し研究プログラム　シーズA

膀胱癌におけるFBXW7の治療抵抗性獲得の解明およびctDNAによる予後予測

2022年4月 - 2027年3月

膀胱癌におけるFBXW7の治療抵抗性獲得の解明およびctDNAによる予後予測

研究課題/領域番号：22K16791  2022年 - 2026年

日本学術振興会  科学研究費助成事業  若手研究

JCOG1905: 進行性腎細胞癌に対するPD-1経路阻害薬の継続と休止に関するランダム化比較第III相試験

2020年7月 - 2030年7月

九州大学　泌尿器科